By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – BioSeek has received $696,000 in funding from the US Environmental Protection Agency to continue providing cell-based assay screening support for the EPA ToxCast screening program, the Asterand subsidiary said today.

BioSeek said that under the phase II funding it will continue to use its BioMap Systems platform, which combines human cell-based assay data with clinically relevant results, to study compounds for their potential toxicity and effects on human health.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.